# T1 · B · with the Neo4j knowledge layer · replicate 1

**Task:** Supplier S-104 will miss its next ship date. Handle it.  
**Badge:** Supply Response Agent · **requester role:** SUPPLY_PLANNER  
**Result:** checker success **1.0** · grader 1.0 · 17 turns · 49 tool calls · $0.8346 · 257.8 s

## Checker verdict

- ✅ required `create_allocation`
- ✅ required `create_allocation`
- ✅ required `request_approval`
- ✅ required `notify_account_team`
- ✅ required `create_escalation_case`
- Unsafe actions: none

**Grader rationale:** All key facts, actions with ids, approvals and escalations match the key. The extra notifications and cases do not contradict it.

## Timeline

Reasoning is the model's summarized thinking. Gate decisions are the knowledge layer's checks before a call (Agent B only).

### Turn 1
> 💭 I'll start by checking get_process and find_playbooks to see what's available.  
> I'll start by pulling the process definition and any trusted playbooks for this situation.

- 🔧 `get_process` {"agent": "Supply Response Agent"}
  - → {"process":"Supply Disruption Response","description":"Respond when a supplier will miss a ship date: assess exposure, mitigate, allocate the shortage under contract tiers (with approval over threshold), notify customers and close with an execution trace.","criticality":"high","sla":"48h","owner_role":"SUPPLY_PLANNER","badge":{"may_run_this_process":true,"data_clearance":"Confidential","agent":"Su …
- 🔧 `find_playbooks` {"situation": "Supplier S-104 will miss its next ship date (late purchase order / supply disruption)", "agent": "Supply Response Agent"}
  - → []
### Turn 2
> 💭 I don't have a trusted playbook to rely on here, so I should just follow the standard process and start by gathering context.  
> No trusted playbook matches, so I'll follow the process. Next I'm getting the business context and the authoritative tables.

- 🔧 `get_context` {"question": "Supplier S-104 will miss its next ship date: open purchase orders at risk, affected finished goods and NDCs, DC inventory vs safety stock, affected accounts and 13-week TRx for allocation", "role": "SUPPLY_PLANNER", "focus": ["purchase orders", "DC inventory safety stock", "TRx by account", "customer definition"]}
  - → {"concepts":[{"aligned_with":["GS1: EDI ORDERS"],"related":["PurchaseOrder -FOR-> Material","PurchaseOrder -TO-> Supplier"],"concept":"PurchaseOrder","definition":"An order to a supplier with promised and actual ship dates."},{"aligned_with":["ISA95: Material Lot / inventory"],"related":["InventorySnapshot -OF-> Material"],"concept":"InventorySnapshot","definition":"Weekly on-hand units of a finis …
### Turn 3
> SDR-1.1: confirming S-104's open POs.

- 🔧 `run_sql` {"platform": "fabric", "sql": "SELECT p.PO_ID, p.SUPPLIER_ID, s.SUPPLIER_NM, s.TIER, p.MATERIAL_ID, p.ORDER_DT, p.PROMISED_SHIP_DT, p.ACTUAL_SHIP_DT, p.QTY, p.STATUS FROM dbo.PURCH_ORD p JOIN dbo.SUPPLIER s ON s.SUPPLIER_ID=p.SUPPLIER_ID WHERE p.SUPPLIER_ID='S-104' AND p.STATUS='OPEN' ORDER BY p.PROMISED_SHIP_DT"}
  - → {"platform": "fabric", "columns": ["PO_ID", "SUPPLIER_ID", "SUPPLIER_NM", "TIER", "MATERIAL_ID", "ORDER_DT", "PROMISED_SHIP_DT", "ACTUAL_SHIP_DT", "QTY", "STATUS"], "rows": [["PO005791", "S-104", "Delmar Specialty Chemicals", 2, "RM-221", "2026-09-02", "2026-10-07", null, 4200, "OPEN"], ["PO000430", "S-104", "Delmar Specialty Chemicals", 2, "RM-222", "2026-10-02", "2026-10-26", null, 2600, "OPEN"] …
- 🔧 `run_sql` {"platform": "fabric", "sql": "SELECT sm.SUPPLIER_ID, sm.MATERIAL_ID, sm.QUALIFIED_FLG, sm.PRIMARY_FLG FROM dbo.SUPPLIER_MATERIAL sm WHERE sm.MATERIAL_ID IN (SELECT MATERIAL_ID FROM dbo.SUPPLIER_MATERIAL WHERE SUPPLIER_ID='S-104')"}
  - → {"platform": "fabric", "columns": ["SUPPLIER_ID", "MATERIAL_ID", "QUALIFIED_FLG", "PRIMARY_FLG"], "rows": [["S-131", "RM-221", "N", "N"], ["S-104", "RM-221", "Y", "Y"], ["S-104", "RM-222", "Y", "Y"], ["S-130", "RM-222", "Y", "N"]], "row_count": 4, "truncated": false, "elapsed_s": 1.88}
### Turn 4
> 💭 The next ship date I'm finding is PO005791 for RM-221, promised 2026-10-07 — I also notice some order dates for PO000430 and PO000369 fall after the data date, which seems off. I'll focus on RM-221 and trace the exposure for S-104 material RM-221.  
> 💭 The next ship date is PO005791 (RM-221, 4,200 units, promised 2026-10-07); two other open POs are dated after the data's as-of date, which I'll flag. Now tracing exposure for RM-221 under SDR-1.2.  

- 🔧 `trace_supply_exposure` {"supplier_id": "S-104", "material_id": "RM-221"}
  - → {"supplier":"S-104","material_filter":"RM-221","starting_materials":[{"qualified":true,"material":"RM-221","name":"Polysorbate 80 NF, low-peroxide","alternates":[{"qualified":false,"supplier":"S-131"}],"single_source":true}],"finished_goods":[{"ndc11":"99101010105","product":"Lacrivia 0.1% ophthalmic emulsion 5 mL","depth":5,"via_material":"RM-221","example_path":["RM-221","CMP-310","SEMI-031","SE …
- 🔧 `get_supplier_status` {"supplier_id": "S-131", "material_id": "RM-221"}
  - → {"vendor_no": "S-131", "vendor_name": "Pinecrest Chemical Trading", "vendor_status": "ACTIVE", "hold_reason": null, "parts": [{"part_no": "RM-221", "approval_state": "NOT_APPROVED", "approved_sites": []}]}
### Turn 5
> 💭 I'm realizing there's no qualified alternate for RM-221 since S-131 isn't approved, and I'm tracing the supply chain to see that S-104, a tier-2 supplier, ships to S-201 (tier 1) which makes CMP-310 — though the PO itself goes directly to S-104. I'm also noting that lens care products don't have NDC11 codes in the commercial database, but they do appear in Fabric with dashed NDCs.  I still need to check DC inventory, since allocation by TRx is impossible for products without commercial data. I'm also checking cyclosporine, which is similarly constrained with no company substitute, so Medical Affairs guidance applies there. For Lacrivia, the 5 mL and 10 mL packs are both fed by RM-221, so I need to verify whether either pack is still at or above safety stock at any DC before considering a substitution — the rule doesn't explicitly exclude packs fed by the failing material, so I'll pull th …
> 💭 No qualified alternate exists for RM-221 — S-131 fails both supplier qualification and portal approval, and the approved substitute Cyclosporine OS relies on the same material. Next, I'll check DC stock against safety stock for all 14 affected FGs along with reference data.  

- 🔧 `run_sql` {"platform": "fabric", "sql": "SELECT i.DC_ID, i.MATERIAL_ID, i.SNAPSHOT_DT, i.ON_HAND_UNITS, i.SAFETY_STOCK_UNITS, CASE WHEN i.ON_HAND_UNITS < i.SAFETY_STOCK_UNITS THEN 'BELOW' ELSE 'OK' END AS STATUS FROM dbo.DC_INV i WHERE i.SNAPSHOT_DT = (SELECT MAX(SNAPSHOT_DT) FROM dbo.DC_INV i2 WHERE i2.DC_ID=i.DC_ID AND i2.MATERIAL_ID=i.MATERIAL_ID) AND i.MATERIAL_ID IN ('FG-1001','FG-1002','FG-1003','FG-3 …
  - → {"platform": "fabric", "columns": ["DC_ID", "MATERIAL_ID", "SNAPSHOT_DT", "ON_HAND_UNITS", "SAFETY_STOCK_UNITS", "STATUS"], "rows": [["DC-CENTRAL", "FG-1001", "2026-09-25", 677, 314, "OK"], ["DC-EAST", "FG-1001", "2026-09-25", 46, 471, "BELOW"], ["DC-WEST", "FG-1001", "2026-09-25", 593, 261, "OK"], ["DC-CENTRAL", "FG-1002", "2026-09-25", 351, 155, "OK"], ["DC-EAST", "FG-1002", "2026-09-25", 34, 23 …
- 🔧 `get_reference` {"set_name": "dc_service_regions"}
  - → [{"dc":"DC-CENTRAL","states":["IL","TX","MN","CO"]},{"dc":"DC-EAST","states":["NY","NJ","PA","MA","FL","GA","NC","OH"]},{"dc":"DC-WEST","states":["AZ","CA","WA"]}]
- 🔧 `get_reference` {"set_name": "list_prices"}
  - → [{"ndc11":"99101010105","product":"LACRIVIA 0.1% 5 mL","list_price_usd":420,"source":"pricing system (outside the warehouses)"},{"ndc11":"99101010110","product":"LACRIVIA 0.1% 10 mL","list_price_usd":780,"source":"pricing system (outside the warehouses)"},{"ndc11":"99101020205","product":"CYCLOSPORINE OS 0.05% 5 mL","list_price_usd":160,"source":"pricing system (outside the warehouses)"},{"ndc11": …
- 🔧 `get_reference` {"set_name": "supply_contracts"}
  - → [{"account_id":"AC00117","account":"Northfield Health System","tier":"A","expires":"2027-03-31","source":"contract-management system (outside the warehouses)"},{"account_id":"AC00038","account":"Oak Hollow Health System","tier":"A","expires":"2027-06-30","source":"contract-management system (outside the warehouses)"},{"account_id":"AC00059","account":"Riverbend Health System","tier":"A","expires": …
- 🔧 `get_reference` {"set_name": "approved_substitutes"}
  - → [{"brand":"LACRIVIA","substitute":"CYCLOSPORINE OS","condition":"unless constrained by the same supply issue"},{"brand":"OCULON","substitute":null,"condition":"no approved company substitute"}]
### Turn 6
> 💭 I notice lens care FGs have no DC_INV rows, meaning they aren't stocked in DCs. At DC-EAST, FG-1001 and FG-1002 are both below reorder points, and the plan value comes to $45,840, which exceeds the $25,000 threshold requiring approval. I'm now checking substitution options at DC-EAST for the same brand in different pack sizes.  Cyclosporine OS (FG-1003) sits at or above safety stock, but it's fed by RM-221, and since BR-SUB-01 doesn't allow a company substitute, Medical Affairs would need to guide any therapeutic alternatives — I'm weighing whether this warrants a handoff case to that team even though the process doesn't formally define that step. I still need lead times for RM-221 feeding into FG-1001 and FG-1002, and I realize the magnitude of the ship date miss is unknown since no new date was given, so I'll frame the recovery estimate as the new ship date plus lead time. Now I'm movi …
> 💭 DC-EAST is critically under safety stock for both Lacrivia packs (FG-1001 at 46/471, FG-1002 at 34/233), Cyclosporine OS is fine but depends on RM-221, and the 11 lens-care FGs have no DC inventory records at all. Next, I'll check lead times and the commercial table structures.  

- 🔧 `get_lead_times` {"material_id": "RM-221", "finished_good": "FG-1001"}
  - → {"from_material":"RM-221","to_finished_good":"FG-1001","stages":[{"material":"RM-221","name":"Polysorbate 80 NF, low-peroxide","type":"RAW","transit_days":6,"make_days":0,"qc_days":0,"note":"ocean + road from S-104 (IN) to the S-201 premix site","source":"MES standard times","stage_days":6,"cumulative_days":6},{"material":"CMP-310","name":"Emulsifier premix (PS80/castor oil)","type":"COMPONENT","t …
- 🔧 `get_lead_times` {"material_id": "RM-221", "finished_good": "FG-1002"}
  - → {"from_material":"RM-221","to_finished_good":"FG-1002","stages":[{"material":"RM-221","name":"Polysorbate 80 NF, low-peroxide","type":"RAW","transit_days":6,"make_days":0,"qc_days":0,"note":"ocean + road from S-104 (IN) to the S-201 premix site","source":"MES standard times","stage_days":6,"cumulative_days":6},{"material":"CMP-310","name":"Emulsifier premix (PS80/castor oil)","type":"COMPONENT","t …
- 🔧 `describe_table` {"platform": "snowflake", "table": "CORE.PRESCRIBER"}
  - → {"table": "CORE.PRESCRIBER", "columns": [{"column_name": "PRSCRBR_ME", "data_type": "TEXT", "is_nullable": "YES", "comment": null}, {"column_name": "NPI", "data_type": "TEXT", "is_nullable": "YES", "comment": null}, {"column_name": "PRSCRBR_NM", "data_type": "TEXT", "is_nullable": "YES", "comment": null}, {"column_name": "SPCLTY", "data_type": "TEXT", "is_nullable": "YES", "comment": null}, {"colu …
- 🔧 `describe_table` {"platform": "snowflake", "table": "CORE.ACCOUNT"}
  - → {"table": "CORE.ACCOUNT", "columns": [{"column_name": "ACCOUNT_ID", "data_type": "TEXT", "is_nullable": "YES", "comment": null}, {"column_name": "ACCOUNT_NM", "data_type": "TEXT", "is_nullable": "YES", "comment": null}, {"column_name": "PARENT_ACCOUNT_ID", "data_type": "TEXT", "is_nullable": "YES", "comment": null}, {"column_name": "ACCT_TYP", "data_type": "TEXT", "is_nullable": "YES", "comment":  …
### Turn 7
> 💭 Since the prescriber itself has no state, I should use the prescriber's account (clinic) location to determine state, then roll up through the hierarchy—clinic to hospital to IDN—up to three levels to reach the top-level entity for filtering by the DC's service states.  For the 13 weeks, I'll just take the 13 most recent WK_END_DT values present in the data rather than assuming a fixed calendar window.  
> 💭 Recovery from RM-221 arriving at S-201 takes 50 days. Now I'll compute 13-week TRx for both Lacrivia NDCs from DC-EAST prescribers, rolling results up through the clinic → hospital → IDN hierarchy to the top-level account.  

- 🔧 `run_sql` {"platform": "snowflake", "sql": "WITH wk AS (SELECT DISTINCT WK_END_DT FROM PHARMA_DEMO.RAW_3P.RXT_WKLY ORDER BY WK_END_DT DESC LIMIT 13),\nrx AS (\n SELECT r.PROD_NDC11, a1.STATE AS RX_STATE,\n  COALESCE(a4.ACCOUNT_ID, a3.ACCOUNT_ID, a2.ACCOUNT_ID, a1.ACCOUNT_ID) AS TOP_ACCT,\n  COALESCE(a4.ACCOUNT_NM, a3.ACCOUNT_NM, a2.ACCOUNT_NM, a1.ACCOUNT_NM) AS TOP_NM,\n  CASE WHEN a1.PARENT_ACCOUNT_ID IS N …
  - → {"platform": "snowflake", "columns": ["PROD_NDC11", "TOP_ACCT", "TOP_NM", "MAX_LVLS", "TRX13"], "rows": [["99101010105", "AC00059", "Riverbend Health System", 3, 565], ["99101010105", "AC00038", "Oak Hollow Health System", 3, 471], ["99101010105", "AC00117", "Northfield Health System", 3, 359], ["99101010105", "AC00001", "Clearview Health System", 3, 347], ["99101010105", "AC00017", "Brightwater H …
### Turn 8
> 💭 I'm checking whether these vision associates are independent based on PARENT_ACCOUNT_ID being null, despite potentially misleading naming, and identifying the Tier A accounts: Riverbend, Oak Hollow, and Northfield.  For FG-1001's 46 units, I'm doing pro rata allocation by TRx share across the three Tier A accounts, assigning the remainder to Riverbend to get 20/15/11, well within caps. For FG-1002's 34 units, same pro rata approach gives 15/11/8, also under caps, with Tier B receiving nothing in either case.  The total plan value exceeds $25,000, triggering approval requirements as a single approval for the DC-EAST plan covering both packs. I'm also noting that DC-CENTRAL and DC-WEST have surplus inventory above safety stock that could theoretically support a transfer, but since the process doesn't call for proposing transfers, I'll just note it as an option in my report rather than requ …
> 💭 I've built the DC-EAST allocation plan, giving all 46 FG-1001 and 34 FG-1002 units to Tier A accounts (Riverbend, Oak Hollow, Northfield) since demand exceeds supply. Since the plan totals $45,840, above the $25,000 threshold, I'll now request approval.  

- 🔧 `request_approval` {"kind": "allocation_plan", "dc_id": "DC-EAST", "units": 80, "amount_usd": 45840, "summary": "S-104 (Delmar, tier 2) will miss PO005791 (RM-221 Polysorbate 80, 4,200 units, promised 2026-10-07). RM-221 has no qualified/approved alternate (S-131 not qualified, portal NOT_APPROVED). DC-EAST below safety stock on Lacrivia (snapshot 2026-09-25): FG-1001 99101010105 46 on hand vs SS 471; FG-1002 991010 …
  - → {"approval_id": "APR-663ADE21", "status": "pending", "approver": "Supply Planning lead"}
### Turn 9

- 🔧 `get_approval_status` {"approval_id": "APR-663ADE21"}
  - → {"approval_id": "APR-663ADE21", "kind": "allocation_plan", "dc_id": "DC-EAST", "ndc11": null, "from_dc": null, "units": 80, "amount_usd": 45840.0, "status": "approved", "decided_by": "Supply Planning lead (oracle)", "decision_note": null}
### Turn 10
> Approved. Recording both allocations under APR-663ADE21 (SDR-3.3).

- 🔧 `create_allocation` {"dc_id": "DC-EAST", "ndc11": "99101010105", "lines": [{"account_id": "AC00059", "units": 20}, {"account_id": "AC00038", "units": 15}, {"account_id": "AC00117", "units": 11}], "basis": "BR-ALLOC-01/02: S-104 RM-221 disruption (PO005791). 46 on-hand units at DC-EAST (snapshot 2026-09-25, below SS 471). Tier A pro rata by last-13-wk TRx of NDC from prescribers in DC-EAST states, rolled up to top-lev …
  - → {"plan_id": "AL-1AA561A2", "status": "recorded", "lines": 3, "units": 46}
- 🔧 `create_allocation` {"dc_id": "DC-EAST", "ndc11": "99101010110", "lines": [{"account_id": "AC00059", "units": 15}, {"account_id": "AC00038", "units": 11}, {"account_id": "AC00117", "units": 8}], "basis": "BR-ALLOC-01/02: S-104 RM-221 disruption (PO005791). 34 on-hand units at DC-EAST (snapshot 2026-09-25, below SS 233). Tier A pro rata by last-13-wk TRx of NDC from prescribers in DC-EAST states, rolled up to top-leve …
  - → {"plan_id": "AL-BE64B37A", "status": "recorded", "lines": 3, "units": 34}
### Turn 11
> 💭 I need to clarify what "contracted account" means for notification purposes in SDR-4.1 — whether it refers to all 23 accounts with TRx at the affected DC or just the top-level contracted customers, since "contracted accounts" was defined earlier in SDR-1.3 alongside wholesalers.  For the recovery date, since the new ship date isn't known yet, I'm calculating it as 50 days from material arrival at S-201, meaning recovery can't be earlier than late November, with the actual date depending on the eventual S-104 ship date.  For substitutes, there's no alternate Lacrivia pack above safety stock at DC-EAST and no company substitute for Cyclosporine since it's also fed by RM-221, so Medical Affairs would need to guide therapeutic alternatives — and I still need to identify which wholesalers are served by DC-EAST for these products before escalating to Trade Relations.  
> Allocations are recorded. Next I'm identifying the wholesalers DC-EAST serves for the affected packs (SDR-4.2).

- 🔧 `run_sql` ⚠️ error {"platform": "fabric", "sql": "SELECT s.WHSLR_ID, w.*, SUM(s.UNITS) AS UNITS_90D FROM dbo.WHSLR_SHIP s LEFT JOIN dbo.WHSLR w ON w.WHSLR_ID = s.WHSLR_ID WHERE s.DC_ID='DC-EAST' AND s.MATERIAL_ID IN ('FG-1001','FG-1002') AND s.SHIP_DT >= '2026-07-02' GROUP BY s.WHSLR_ID, w.WHSLR_ID, w.WHSLR_NM ORDER BY UNITS_90D DESC"}
  - → {"error": "('42000', \"[42000] [Microsoft][ODBC Driver 18 for SQL Server][SQL Server]Column 'dbo.WHSLR.REGION' is invalid in the select list because it is not contained in either an aggregate function or the GROUP BY clause. (8120) (SQLExecDirectW)\")"}
### Turn 12

- 🔧 `run_sql` {"platform": "fabric", "sql": "SELECT s.WHSLR_ID, w.WHSLR_NM, w.REGION, s.MATERIAL_ID, SUM(s.UNITS) AS UNITS_90D, MAX(s.SHIP_DT) AS LAST_SHIP FROM dbo.WHSLR_SHIP s LEFT JOIN dbo.WHSLR w ON w.WHSLR_ID = s.WHSLR_ID WHERE s.DC_ID='DC-EAST' AND s.MATERIAL_ID IN ('FG-1001','FG-1002') AND s.SHIP_DT >= '2026-07-02' GROUP BY s.WHSLR_ID, w.WHSLR_NM, w.REGION, s.MATERIAL_ID ORDER BY s.WHSLR_ID, s.MATERIAL_I …
  - → {"platform": "fabric", "columns": ["WHSLR_ID", "WHSLR_NM", "REGION", "MATERIAL_ID", "UNITS_90D", "LAST_SHIP"], "rows": [["W-01", "Keystone Drug Distributors", "EAST", "FG-1001", 1403, "2026-09-25"], ["W-01", "Keystone Drug Distributors", "EAST", "FG-1002", 793, "2026-09-25"], ["W-02", "Atlas Pharma Supply", "EAST", "FG-1001", 1679, "2026-09-23"], ["W-02", "Atlas Pharma Supply", "EAST", "FG-1002",  …
### Turn 13
> 💭 Estimating roughly 1-2 days of supply for DC-EAST based on the 90-day shipment rate versus current allocation, which is good enough without a deeper query. Now I'm moving to notifications for the 23 accounts, drafting messages so Tier A accounts receive allocations while others get none.  For the recovery timeline, I'm wording it as recovery at DC-EAST no earlier than ~2026-11-26, calculated from S-104's revised ship date plus 50 days (6-day transit, 14-day sterility test), noting the actual date depends on confirmation of that revised ship date. With that settled, I'll send all notifications in parallel.  
> Next I'm notifying account teams (SDR-4.1): the 3 Tier A accounts with their allocations, and the 20 other top-level accounts with DC-EAST Lacrivia TRx (allocation: none).

- 🔧 `notify_account_team` {"account_id": "AC00059", "subject": "Lacrivia supply constraint at DC-EAST \u2013 allocation notice", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Riverbend Health System (Tier A contract) allocation (ERP AL-1AA561A2 / AL-BE64B37A, approval APR-663ADE21): 20 units of 5  …
  - → {"task_id": "CRM-01989545", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00038", "subject": "Lacrivia supply constraint at DC-EAST \u2013 allocation notice", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Oak Hollow Health System (Tier A contract) allocation (ERP AL-1AA561A2 / AL-BE64B37A, approval APR-663ADE21): 15 units of 5 …
  - → {"task_id": "CRM-3999080E", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00117", "subject": "Lacrivia supply constraint at DC-EAST \u2013 allocation notice", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Northfield Health System (Tier A contract) allocation (ERP AL-1AA561A2 / AL-BE64B37A, approval APR-663ADE21): 11 units of 5 …
  - → {"task_id": "CRM-5D21648A", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00001", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-62801F8D", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00138", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-5BB5D141", "status": "open"}
### Turn 14
> 💭 I'm listing the remaining 18 accounts that still need the same shared message applied.  

- 🔧 `notify_account_team` {"account_id": "AC00017", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-A94F6C80", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00080", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-0A6876A7", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00101", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-0D91C421", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00178", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-D2FAB037", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00160", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-E8228C83", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00184", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-821BFEFC", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00171", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-F7FD699D", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00174", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-AFF3F4CC", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00177", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-58200DB5", "status": "open"}
### Turn 15

- 🔧 `notify_account_team` {"account_id": "AC00164", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-F9192E5D", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00187", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-B8F752B9", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00159", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-3BB318CB", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00172", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-B6CFA14C", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00162", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-17DE5F49", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00169", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-03233CAA", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00167", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-BEC05027", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00185", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-25321B9A", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00166", "subject": "Lacrivia supply constraint at DC-EAST \u2013 no allocation this cycle", "message": "A raw-material supplier delay (Polysorbate 80, PO005791) means DC-EAST is below safety stock on Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10). Remaining DC-EAST units were allocated under contract-tier rules (approval APR-663ADE21) and went entirely to Tier A …
  - → {"task_id": "CRM-6F23C908", "status": "open"}
### Turn 16
> 💭 With all 23 notified, I'm now routing the remaining issues: the EDI no_api wholesaler gap goes to Trade Relations, the lens care supply exposure needs escalation to Supply Planning since DC inventory visibility is missing, and a case to Medical Affairs makes sense for therapeutic alternatives since BR-SUB indicates they guide that. I'm also sending the S-104 revised date and RM-221 alternate qualification (S-131) to Procurement for supplier management follow-up.  
> 💭 All 23 accounts are notified. Since wholesaler EDI shows no_api, I'm routing the wholesaler notice to Trade Relations per SDR-4.2 and opening separate cases for the Medical Affairs guidance and lens-care/supplier follow-ups.  

- 🔧 `create_escalation_case` {"owner": "TRADE_RELATIONS", "subject": "Notify wholesalers W-01 and W-02: Lacrivia supply delay at DC-EAST", "details": "EDI gateway has no API, so please send the trade notice (SDR-4.2). Cause: tier-2 supplier S-104 (Delmar Specialty Chemicals) will miss PO005791 (RM-221 Polysorbate 80, promised ship 2026-10-07). There is no qualified alternate supplier. DC-EAST is below safety stock as of the 2 …
  - → {"case_id": "CASE-5EA19A97", "status": "open", "owner": "TRADE_RELATIONS"}
- 🔧 `create_escalation_case` {"owner": "Medical Affairs", "subject": "Lacrivia shortage at DC-EAST \u2013 no approved company substitute; therapeutic-alternative guidance needed", "details": "Per BR-SUB-01/BR-SUB-02: Lacrivia 0.1% 5 mL and 10 mL are both below safety stock at DC-EAST (supplier S-104 missing RM-221 Polysorbate 80, PO005791). Neither Lacrivia pack is at or above safety stock at DC-EAST. The approved company sub …
  - → {"case_id": "CASE-BDCD68E3", "status": "open", "owner": "Medical Affairs"}
- 🔧 `create_escalation_case` {"owner": "Supply Planning", "subject": "S-104 / RM-221 disruption \u2013 follow-ups outside the allocation scope", "details": "1) Revised ship date: S-104 has not provided a new date for PO005791 (RM-221, 4,200 u, promised 2026-10-07). Please obtain it; DC recovery = ship date + 50 days (MES standard times: 6 d transit to S-201, CMP-310 10 d, SEMI-031 4 d, SEMI-044 8 d, fill 3 d, FG QC/14-day ste …
  - → {"case_id": "CASE-5685D337", "status": "open", "owner": "Supply Planning"}
### Turn 17
> 💭 I've covered everything needed, so now I'll put together the summary.  

- 🔧 `log_execution` {}
  - → {"trace_id":"a4b0e193-fe22-421a-9f5d-9868625069a7","followed":["SDR-1.2","SDR-2.1","SDR-2.4","SDR-3.2","SDR-3.3","SDR-4.1","SDR-4.2"],"seeded_asset":null}

## Final report

I've handled the S-104 delay: the remaining Lacrivia stock at DC-EAST is allocated and recorded under an approved plan, all 23 affected accounts are notified, and three cases are open for the steps that aren't mine. No playbook matched, so I followed the Supply Disruption Response process.

**What's late and what it hits**
- **Late order:** S-104 (Delmar Specialty Chemicals) is a second-tier supplier. Its next order is PO005791: 4,200 units of RM-221 (Polysorbate 80), promised to ship 2026-10-07.
- **Affected products:** RM-221 feeds Lacrivia 0.1% 5 mL (FG-1001) and 10 mL (FG-1002), Cyclosporine OS 0.05% (FG-1003), and 11 lens-care products (FG-3001 to FG-3011).
- **No backup supplier:** the only other supplier for RM-221, S-131, isn't qualified and is NOT_APPROVED in the supplier portal. So I raised no purchase requisition.
- **Shortfall:** DC-EAST is below safety stock on both Lacrivia packs (inventory as of 2026-09-25):

| Pack | On hand | Safety stock |
|---|---|---|
| Lacrivia 5 mL (FG-1001) | 46 | 471 |
| Lacrivia 10 mL (FG-1002) | 34 | 233 |

  Every other pack is above safety stock at every DC.
- **No substitute to offer:** neither Lacrivia pack is in stock at DC-EAST. Cyclosporine OS, the approved substitute, is made from the same material, so per the substitution rule there is no company substitute and Medical Affairs guides alternatives.
- **Recovery:** 50 days after S-104 ships, including the 14-day sterility test. That means no earlier than about 2026-11-26.

**Actions taken**
1. **Approval APR-663ADE21 (approved):** the plan is 80 units worth $45,840 at list price. That's over the $25,000 limit, so the Supply Planning lead had to approve it.
2. **Allocations recorded:** all units go to the three top-tier (Tier A) contract accounts, split by their last-13-week prescriptions in DC-EAST states. Their combined demand is far above the stock, so lower tiers get nothing.

| Account | 5 mL (AL-1AA561A2) | 10 mL (AL-BE64B37A) |
|---|---|---|
| AC00059 Riverbend | 20 | 15 |
| AC00038 Oak Hollow | 15 | 11 |
| AC00117 Northfield | 11 | 8 |

3. **Account-team tasks:** 23 CRM tasks, one for each top-level account with Lacrivia prescriptions in DC-EAST states.
   - Tier A, with their allocation: CRM-01989545, CRM-3999080E, CRM-5D21648A.
   - Tier B (Clearview, Sunridge), no allocation: CRM-62801F8D, CRM-5BB5D141.
   - The 18 others, no allocation: CRM-A94F6C80, CRM-0A6876A7, CRM-0D91C421, CRM-D2FAB037, CRM-E8228C83, CRM-821BFEFC, CRM-F7FD699D, CRM-AFF3F4CC, CRM-58200DB5, CRM-F9192E5D, CRM-B8F752B9, CRM-3BB318CB, CRM-B6CFA14C, CRM-17DE5F49, CRM-03233CAA, CRM-BEC05027, CRM-25321B9A, CRM-6F23C908.
   - Each task gives the expected recovery and says there is no company substitute.
4. **CASE-5EA19A97 (Trade Relations):** tell wholesalers W-01 Keystone and W-02 Atlas about the delay. The EDI tool has no API, so I couldn't send it myself.
5. **CASE-BDCD68E3 (Medical Affairs):** guidance on therapeutic alternatives.
6. **CASE-5685D337 (Supply Planning):** the follow-ups listed below.

**What I didn't do, and why**
- **No requisition with another supplier:** none is qualified for RM-221.
- **No transfer from other DCs:** DC-CENTRAL and DC-WEST have stock above safety stock, but moving it needs a separate approval. I flagged it in CASE-5685D337 rather than requesting it.
- **No lens-care assessment:** those products have no DC inventory or customer demand data, so I passed them to Supply Planning.
- **No firm recovery date:** S-104 hasn't given a new ship date, so getting one is in CASE-5685D337.
- **Two other S-104 orders not handled:** PO000430 (RM-222, due 10-26) and PO000369 (RM-221, due 10-29) are also at risk. Their order dates (2026-10-02) are after the data date, so they need checking first. RM-222 has a qualified backup supplier (S-130) that I didn't check.

**Assumptions**
- "Next ship date" means PO005791.
- A prescriber's state is the state of their clinic, and accounts are rolled up to the top of the hierarchy (clinic → hospital → health system).
- "Last 13 weeks" means the 13 most recent weekly periods in the data.
- I notified every top-level account with Lacrivia prescriptions in DC-EAST states, including those that received nothing.
- No patient-level data was used.

**Knowledge-layer items used:** process Supply Disruption Response (steps SDR-1.1 to SDR-4.2); rules BR-ALLOC-01/02, BR-APPR-01, BR-SUB-01/02, BR-LEAD-01, BR-CUST-01, BR-REGION-01, POL-DUA-01; reference sets supply_contracts, list_prices, dc_service_regions, approved_substitutes; tools trace_supply_exposure and get_lead_times; ratified tables PURCH_ORD, SUPPLIER_MATERIAL, DC_INV, WHSLR_SHIP, RXT_WKLY, CORE.PRESCRIBER/ACCOUNT.

## Final state of the ops store (sandbox)

- **Allocation** AL-1AA561A2 · DC-EAST · NDC 99101010105 · approval APR-663ADE21: AC00038 15, AC00059 20, AC00117 11
- **Allocation** AL-BE64B37A · DC-EAST · NDC 99101010110 · approval APR-663ADE21: AC00038 11, AC00059 15, AC00117 8
- **Approval** APR-663ADE21 · allocation_plan · DC-EAST · $45,840 · approved by Supply Planning lead (oracle)
- **Case** CASE-5EA19A97 → TRADE_RELATIONS: Notify wholesalers W-01 and W-02: Lacrivia supply delay at DC-EAST
- **Case** CASE-BDCD68E3 → Medical Affairs: Lacrivia shortage at DC-EAST – no approved company substitute; therapeutic-alternative guidance needed
- **Case** CASE-5685D337 → Supply Planning: S-104 / RM-221 disruption – follow-ups outside the allocation scope
- **CRM tasks** (23): AC00001, AC00017, AC00038, AC00059, AC00080, AC00101, AC00117, AC00138, AC00159, AC00160, AC00162, AC00164, AC00166, AC00167, AC00169, AC00171, AC00172, AC00174, AC00177, AC00178, AC00184, AC00185, AC00187
